Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jan 29, 2020
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Policy Notices
- Additional Guidance on the NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research
National Institutes of Health
- Update of NIH Continuous Submission Policy: Change in Submission Deadlines and End of Recent Substantial Service Option
Center for Scientific Review
General Notices
- Notice of a Pre-Application Webinar for NIDCR Institutional Training Program FOAs: T32 (PAR-20-044) and T90/R90 (PAR-20-056)
National Institute of Dental and Craniofacial Research
- Notice of Pre-Application Webinars for the Mendelian Genomics Research Centers (RFA-HG-20-007) and Mendelian Genomics Data Coordinating Center (RFA-HG-20-008)
National Human Genome Research Institute
- NHLBI Announces http://ags20.od.nih.gov/view/Index.cfmPlan to Fund a Women's Health Initiative Home-Based Exam in the Long Life Study 2 Cohort
National Heart, Lung, and Blood Institute
- Notice of NCATS Interest in Receiving Letters Requesting Permission to Submit Applications to Support Annual Microphysiological Systems Scientific Conferences (U13)
National Center for Advancing Translational Sciences
- Request for Information (RFI): Interest in data and specimens from the Hemophilia Growth and Development Study (HGDS) for research on HIV-associated comorbidities, coinfections and complications
National Heart, Lung, and Blood Institute
Notice of Changes to Funding Opportunities
- Notice to Extend NCCIH PAR-18-663, "Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)"
National Center for Complementary and Integrative Health
- Notice to Extend NCCIH's PAR-18-118, "NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)"
National Center for Complementary and Integrative Health
- Notice of Clarification Relevant to Section IV, Application and Submission Information for PAR-20-046 NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
- Notice of Clarification Relevant to Section IV, Application and Submission Information for PAR-20-045 NIDCR Research Grants for Analyses of Existing Genomics Data (R01 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
- Notice of Change in Expiration Date of PAR-18-643 "NHLBI Clinical Ancillary Studies (R01 Clinical Trial Optional)"
National Heart, Lung, and Blood Institute
- Notice of Participation of the NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
National Institute of Mental Health
- Notice to Extend RFA-MH-20-310 BRAIN Initiative: Non-Invasive Neuromodulation - New Tools and Techniques for Spatiotemporal Precision (R01 Clinical Trial Optional)
National Institute of Mental Health
Funding Opportunities
- Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
National Institute on Drug Abuse
- Harmonization of Alzheimers Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed)
National Institute on Aging
- Genomic Community Resources (U24 Clinical Trial Not Allowed)
National Human Genome Research Institute
National Cancer Institute
- Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Cancer Institute
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
- HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)
National Center for Complementary and Integrative Health
National Center for Advancing Translational Sciences
National Cancer Institute
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
- HEAL Initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development (R61/R33 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
- HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
- Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
- Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
- Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
- Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)
- Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)
- Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)
National Cancer Institute
- HIV/AIDS and the Tumor Niche (U54 Clinical Trial Not Allowed)
National Cancer Institute
- Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) (U18) Clinical Trials Not Allowed
Food and Drug Administration
- Building an Integrated Laboratory System to Advance the Safety of Human and Animal Food (U18) Clinical Trial Not Allowed
Food and Drug Administration
- Conduct Studies to Establish More Targeted Durations of Use for Certain Approved Antimicrobial New Animal Drugs in Food Animals (U01) Clinical Trials Optional
Food and Drug Administration
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu